JUL 12, 2016 12:57 PM PDT

PDE4B Inhibitor to Treat Traumatic Brain Injury

WRITTEN BY: Cassidy Reich
Traumatic brain injuries (TBI) are the leading cause of death and disability for Americans under the age of 45. Specifically, 5 million people in the U.S. are living with a chronic disability due to a TBI. There is currently no effective drug to help those with TBI, but there is a great demand for some such therapeutic. Not only would an effective TBI therapeutic restore the learning and memory deficits in those affected, but would lower the cost of TBIs, which currently stands at the astounding number of $76.5 billion annually.


As you might imagine from the name “traumatic brain injury,” a TBI is caused by an impact to the head. TBIs by themselves can be fatal, but of those who survive, ~80% experience problems with learning and memory in the months and years after the trauma. Drugs such as Ritalin (methylphenidate) and Aricept (donepezil) are sometimes used to help manage the deficits, but neither one treats the underlying cause. Both drugs, though they operate on different neurotransmitter systems, functional similarly in that they increase attention and paying attention is the first step in learning and memory. However, they do not affect the downstream processes of memory formation.

A recent effort between the University of Miami and The Miami Project to Cure Paralysis determines the brain changes that occur in the months after a TBI that affect learning and memory and also tests a drug candidate to correct these changes. The paper, entitled “Chronic Cognitive Dysfunction after Traumatic Brain Injury is Improved with a Phosphodiesterase 4B Inhibitor,” was recently published in The Journal of Neuroscience.

The researchers induced TBI in rats and left them untreated for 3 months before looking for changes in the brain. What they found was decreased levels of 2 proteins, cAMP and CREB, that are crucial for learning and memory formation. In a healthy, non-traumatized brain, neuronal activity elevates cAMP levels which in turn activates CREB to strengthen synaptic connections, induce long term potentiation, and form memories.

By using a very specific enzyme inhibitor, the researchers hoped to inhibit the degradation of cAMP to increase the amount available to activate CREB. This strategy has been tried in the past, but with less specific inhibitors that caused undesirable effects. The use of a specific phosphodiesterase 4B inhibitor (PDE4B inhibitor) instead of a pan-PDE4 inhibitor looks very promising in the rat model of TBI. 3 months after an untreated TBI, administration of the specific PDE4B inhibitor restored memory deficits in the injured rats to nearly non-injured levels without causing the side effects of emesis and diarrhea.

The PDE4B inhibitor used in the study is in the company Tetra Discovery’s pipeline and is being tested for other indications as well. There is hope that this specific PDE4B inhibitor can be used for other neurological disorders such as schizophrenia and depression. Some kind of therapeutic for the learning and memory deficits in TBI is needed, and Tetra’s compound looks like a good start.

Sources: FierceBiotech and PR Newswire
About the Author
  • Cassidy is a curious person, and her curiosity has led her to pursue a PhD in Pharmacology at the New York University Sackler Institute of Biomedical Sciences. She likes to talk about science way too much, so now she's going to try writing about it.
You May Also Like
OCT 08, 2020
Immunology
Air Pollution Particles Detected in the Placenta, Immune Cells Mop Them Up
OCT 08, 2020
Air Pollution Particles Detected in the Placenta, Immune Cells Mop Them Up
Tiny, black particles much like those found in polluted air have been found in the placentas of pregnant women, as repor ...
OCT 06, 2020
Microbiology
Scarlet Fever 'Superclones' Pose Rising Public Health Threat
OCT 06, 2020
Scarlet Fever 'Superclones' Pose Rising Public Health Threat
More than 100 years ago, the world faced waves of scarlet fever epidemics; between around 1820 and 1880 there were sever ...
OCT 07, 2020
Genetics & Genomics
Researchers Confirm Cerebral Palsy Has a Genetic Component
OCT 07, 2020
Researchers Confirm Cerebral Palsy Has a Genetic Component
Scientists have confirmed previous studies that have suggested that some cases of cerebral palsy are due to a genetic mu ...
OCT 18, 2020
Cell & Molecular Biology
Small RNA is Connected to Bacterial Pathogenicity
OCT 18, 2020
Small RNA is Connected to Bacterial Pathogenicity
It's thought that as much as half of the global population carries a bacterium called Helicobacter pylori in their stoma ...
OCT 21, 2020
Cell & Molecular Biology
Extracellular Vesicles Help Heart Cells Survive a Heart Attack
OCT 21, 2020
Extracellular Vesicles Help Heart Cells Survive a Heart Attack
During a heart attack, blood flow is blocked and cells lose oxygen and begin to die. Scientists are developing many new ...
OCT 26, 2020
Genetics & Genomics
Does a 'Mismatch' Between Diet and Biology Cause Poor Health?
OCT 26, 2020
Does a 'Mismatch' Between Diet and Biology Cause Poor Health?
People that eat a 'paleo' diet operate under the idea that we should be eating more like our ancestors, and that metabol ...
Loading Comments...